Abstract
Virally-directed fluorescence imaging has the potential to revolutionize intra-operative oncologic staging and tumor resection. Many viruses genetically engineered to specifically infect tumor cells as cancer therapy can be further modified to have a visible marker gene for cancer staging. In this chapter, we describe such a herpes simplex virus (HSV) modified to be detected by fluorescence. Other viruses so designed can be similarly used in cancer detection and staging. Replication-competent, tumor-specific HSV NV1066 expresses green fluorescent protein (GFP) in infected cancer cells. One single dose of NV1066 administered via intratumor, intracavitary, or systemic injection can spread within and across body cavities to target tumor cells while sparing normal tissue cells from infection. Tumors otherwise invisible by conventional laparoscopy appear green with the use of an endoscope equipped with a fluorescent filter. Furthermore, with GFP expression easily visualized by stereomicroscopy, microscopic, and pathologic analysis is significantly enhanced. This chapter addresses NV1066-directed visualization of peritoneal, pleural, and lymphatic metastases. This chapter also provides protocols for the production of tumor models in various body cavities in rodents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jarnagin, W.R., Conlon, K., Bodniewicz, J., Dougherty, E., DeMatteo, R.P., Blumgart, L.H., et al. (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91(6), 1121–1128.
Paraskeva, P.A., Purkayastha, S., Darzi, A. (2004) Laparoscopy for malignancy: current status. Seminars in Laparoscopic Surgery 11(1), 27–36.
Parra, J.L., Reddy, K.R. (2004) Diagnostic laparoscopy. Endoscopy 36(4), 289–293.
Corvera, C.U., Blumgart, L.H., Darvishian, F., Klimstra, D.S., DeMatteo, R., Fong, Y., et al. (2005) Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg 201(6), 862–869.
Sugarbaker, P.H. (2004) Managing the peritoneal surface component of gastrointestinal cancer. Part 2. Perioperative intraperitoneal chemotherapy. Oncology (Williston Park) 18(2), 207–219.
Sugarbaker, P.H. (2001) Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. European Journal Of Surgical Oncology 27(3), 239–243.
Yonemura, Y., Bandou, E., Kinoshita, K., Kawamura, T., Takahashi, S., Endou, Y., et al. (2003) Effective therapy for peritoneal dissemination in gastric cancer. Surgical Oncology Clinics of North America 12(3), 635–648.
Rusch, V.W., Rosenzweig, K., Venkatraman, E., Leon, L., Raben, A., Harrison, L., et al. (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122(4), 788–795.
Jaklitsch, M.T., Grondin, S.C., Sugarbaker, D.J. (2001) Treatment of malignant mesothelioma. World J Surg 25(2), 210–217.
Rusch, V.W. (1999) Indications for pneumonectomy. Extrapleural pneumonectomy. Chest Surg Clin N Am 9(2), 327–338.
Rusch, V.W., Venkatraman, E.S. (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68(5), 1799–1804.
Sugarbaker, P.H. Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options. Oncology (Williston Park) 18(1), 51–59.
Verwaal, V.J., van Ruth,. S, Witkamp, A., Boot, H., van Slooten, G., Zoetmulder, F.A. (2005) Long-term survival of peritoneal carcinomatosis of colorectal origin. Annals of Surgical Oncology 12(1), 65–71.
D’Angelica, M., Fong, Y., Weber, S., Gonen, M., DeMatteo, R.P., Conlon, K., et al. (2003) The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Annals of Surgical Oncology 10(2), 183–189.
Jiao, X., Krasna, M.J. (2002) Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 74(1), 278–284.
Veronesi, U., Galimberti, V., Mariani, L., Gatti, G., Paganelli, G., Viale, G., et al. (2005) Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. European Journal Of Cancer 41(2), 231–237.
Kelley, M.C., Hansen, N., McMasters, K.M. (2004) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. American Journal Of Surgery 188(1), 49–61.
Liu, T.C., Galanis, E., Kirn, D. (2007) Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol 4(2), 101–117.
Reinblatt, M., Pin, R.H., Fong, Y. (2007) Herpes viral oncolysis: a novel cancer therapy. J Am Coll Surg 205(4 Suppl), S69–S75.
Bennett, J.J., Delman, K.A., Burt, B.M., Mariotti, A., Malhotra, S., Zager, J., et al. (2002) Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Therapy 9(11), 935–945.
Wong, R.J., Joe, J.K., Kim, S.H., Shah, J.P., Horsburgh, B., Fong, Y.M. (2002) Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic Metastases. Human Gene Therapy 13(10), 1213–1223.
Wong, R.J., Kim, S.H., Joe, J.K., Shah, J.P., Johnson, P.A., Fong, Y. (2001) Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. Journal of the American College of Surgeons 193(1), 12–21.
McAuliffe, P.F., Jarnagin, W.R., Johnson, P., Delman, K.A., Federoff, H., Fong, Y. (2000) Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses. Journal of Gastrointestinal Surgery 4(6), 580–588.
Stiles, B.M., Bhargava, A., Adusumilli, P.S., Stanziale, S.F., Kim, T.H., Rusch,V.W., et al. (2003) The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer. Surgery 134(2), 357–364.
Stanziale, S.F., Petrowsky, H., Adusumilli, P.S., Ben Porat, L., Gonen, M., Fong, Y. (2004) Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity. Clinical Cancer Research 10(9), 3225–3232.
Adusumilli, P.S., Eisenberg, D.P., Stiles, B.M., Hendershott, K.J., Stanziale, S.F., Chan, M.K., et al. (2006) Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging. Surgical Endoscopy 20(4), 628–635.
Stanziale, S.F., Stiles, B.M., Bhargava, A., Kerns, S.A., Kalakonda, N., Fong, Y. (2004) Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer. Hum Gene Ther 15(6), 609–618.
Adusumilli, P.S., Eisenberg, D.P., Chun, Y.S., Ryu, K.W., Ben-Porat, L., Hendershott, K.J., et al. (2005) Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. Journal of Gastrointestinal Surgery 9(8), 1138–1147.
Adusumilli, P.S., Stiles, B.M., Chan, M.K., Eisenberg, D.P., Yu, Z., Stanziale, S.F., et al. (2006) Real-time Diagnostic Imaging of Tumors and Metastases by Use of a Replication-competent Herpes Vector to Facilitate Minimally-Invasive Oncological Surgery. FASEB J 20(6), 726–728.
Gahlen, J., Stern, J., Laubach, H.H., Pietschmann, M., Herfarth, C. (1999) Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic fluorescence diagnosis. Surgery 126(3), 469–473.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prasher, D.C. (1994) Green fluorescent protein as a marker for gene expression. Science 263(5148), 802–805.
Cormack, B.P., Valdivia, R.H., Falkow, S. (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173(1 Spec No), 33–38.
Adusumilli, P.S., Eisenberg, D.P., Stiles, B.M., Chung, S., Chan, M.K., Rusch, V.W., et al. (2006) Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus. J Thorac Cardiovasc Surg 132(5), 1179–1188.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Carpenter, S., Fong, Y. (2012). Real-Time Fluorescence Imaging of Abdominal, Pleural, and Lymphatic Metastases. In: Hoffman, R. (eds) In Vivo Cellular Imaging Using Fluorescent Proteins. Methods in Molecular Biology, vol 872. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-797-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-61779-797-2_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-796-5
Online ISBN: 978-1-61779-797-2
eBook Packages: Springer Protocols